Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Agnosia × Tapentadol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 4 Neoplasms 3 Chronic Pain 1 Cancer Pain 1 Agnosia 1

Interventions

Sodium Chloride 2 Ropivacaine 2 Propofol 2 Ketamine 2 Analgesics, Opioid 2 Analgesia, Patient-Controlled 2 parecoxib 1 Tea 1 Tapentadol 1 Surveys and Questionnaires 1 Sevoflurane 1 Lidocaine 1 Ketorolac 1 Epinephrine 1 Dexamethasone 1 Clonidine 1 Celecoxib 1 Anesthesia, General 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01264887 2019-11-04

Tapentadol in Chronic Malignant Tumour Related Pain

Grünenthal GmbH

Phase 3 Terminated

31 enrolled 19 charts

Agnosia, Neoplasms, Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡